Irmgard Assfalg‐Machleidt

1.8k total citations
49 papers, 1.5k citations indexed

About

Irmgard Assfalg‐Machleidt is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Irmgard Assfalg‐Machleidt has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Cancer Research and 12 papers in Cell Biology. Recurrent topics in Irmgard Assfalg‐Machleidt's work include Protease and Inhibitor Mechanisms (18 papers), Calpain Protease Function and Regulation (10 papers) and Enzyme Production and Characterization (10 papers). Irmgard Assfalg‐Machleidt is often cited by papers focused on Protease and Inhibitor Mechanisms (18 papers), Calpain Protease Function and Regulation (10 papers) and Enzyme Production and Characterization (10 papers). Irmgard Assfalg‐Machleidt collaborates with scholars based in Germany, United States and Slovenia. Irmgard Assfalg‐Machleidt's co-authors include Werner Machleidt, Ennes A. Auerswald, Luis Moroder, Hans Fritz, Norbert Schaschke, Marianne Jochum, Dorit K. Nägler, Vito Türk, Christoph O. Randak and Janko Kos and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

Irmgard Assfalg‐Machleidt

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irmgard Assfalg‐Machleidt Germany 24 864 366 335 293 190 49 1.5k
Douglas A. Weidner United States 22 965 1.1× 156 0.4× 374 1.1× 131 0.4× 106 0.6× 46 1.7k
Horst Ahorn Austria 26 1.6k 1.8× 145 0.4× 240 0.7× 277 0.9× 183 1.0× 37 2.5k
Stefan Müller Germany 28 1.6k 1.9× 186 0.5× 262 0.8× 247 0.8× 137 0.7× 51 2.4k
Mikhail A. Nikiforov United States 30 2.1k 2.4× 486 1.3× 580 1.7× 376 1.3× 284 1.5× 69 2.8k
Robert Schimke United States 18 1.5k 1.7× 294 0.8× 323 1.0× 321 1.1× 163 0.9× 25 2.2k
M.D. Zimmerman United States 18 772 0.9× 416 1.1× 397 1.2× 93 0.3× 120 0.6× 27 1.7k
Chunqing Guo United States 29 1.5k 1.7× 520 1.4× 611 1.8× 242 0.8× 96 0.5× 66 2.9k
Howard O. Fearnhead Ireland 26 2.0k 2.4× 327 0.9× 489 1.5× 235 0.8× 82 0.4× 53 2.6k
Ing Swie Goping Canada 26 2.2k 2.5× 417 1.1× 498 1.5× 442 1.5× 133 0.7× 52 3.4k
Giorgio Fassina Italy 30 1.6k 1.9× 174 0.5× 258 0.8× 237 0.8× 115 0.6× 117 2.7k

Countries citing papers authored by Irmgard Assfalg‐Machleidt

Since Specialization
Citations

This map shows the geographic impact of Irmgard Assfalg‐Machleidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irmgard Assfalg‐Machleidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irmgard Assfalg‐Machleidt more than expected).

Fields of papers citing papers by Irmgard Assfalg‐Machleidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irmgard Assfalg‐Machleidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irmgard Assfalg‐Machleidt. The network helps show where Irmgard Assfalg‐Machleidt may publish in the future.

Co-authorship network of co-authors of Irmgard Assfalg‐Machleidt

This figure shows the co-authorship network connecting the top 25 collaborators of Irmgard Assfalg‐Machleidt. A scholar is included among the top collaborators of Irmgard Assfalg‐Machleidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irmgard Assfalg‐Machleidt. Irmgard Assfalg‐Machleidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiorino, Ferdinando, Shirley Gil-Parrado, Irmgard Assfalg‐Machleidt, Werner Machleidt, & Luis Moroder. (2006). A new cell‐permeable calpain inhibitor. Journal of Peptide Science. 13(1). 70–73. 10 indexed citations
2.
Fernández‐Montalván, Amaury E., et al.. (2006). μ-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation. Biological Chemistry. 387(5). 617–27. 9 indexed citations
3.
Kaiser, Markus, M. Groll, Carlo Siciliano, et al.. (2004). Binding Mode of TMC‐95A Analogues to Eukaryotic 20S Proteasome. ChemBioChem. 5(9). 1256–1266. 45 indexed citations
4.
Gil-Parrado, Shirley, Irmgard Assfalg‐Machleidt, Ferdinando Fiorino, et al.. (2003). Calpastatin Exon 1B-Derived Peptide, a Selective Inhibitor of Calpain: Enhancing Cell Permeability by Conjugation with Penetratin. Biological Chemistry. 384(3). 395–402. 26 indexed citations
5.
Sato, Sumito, et al.. (2003). Novel Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems. Biological Chemistry. 384(7). 1085–96. 8 indexed citations
6.
Gil-Parrado, Shirley, Amaury E. Fernández‐Montalván, Irmgard Assfalg‐Machleidt, et al.. (2002). Ionomycin-activated Calpain Triggers Apoptosis. Journal of Biological Chemistry. 277(30). 27217–27226. 180 indexed citations
7.
Schaschke, Norbert, et al.. (2000). β-Cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells. Bioorganic & Medicinal Chemistry Letters. 10(7). 677–680. 24 indexed citations
8.
Schaschke, Norbert, et al.. (2000). Epoxysuccinyl peptide‐derived affinity labels for cathepsin B. FEBS Letters. 482(1-2). 91–96. 31 indexed citations
9.
Schaschke, Norbert, Hans‐Jürgen Musiol, Irmgard Assfalg‐Machleidt, Werner Machleidt, & Luis Moroder. (1997). Oligopresentation of protease inhibitors with β-cyclodextrin as template. Bioorganic & Medicinal Chemistry Letters. 7(19). 2507–2512. 6 indexed citations
10.
Randak, Christoph O., Peter Neth, Ennes A. Auerswald, et al.. (1996). A recombinant polypeptide model of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator is a GTP‐binding protein. FEBS Letters. 398(1). 97–100. 13 indexed citations
11.
Schaschke, Norbert, et al.. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS Letters. 391(3). 297–301. 17 indexed citations
12.
Auerswald, Ennes A., Dorit K. Nägler, Irmgard Assfalg‐Machleidt, et al.. (1995). Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain. FEBS Letters. 361(2-3). 179–184. 35 indexed citations
13.
14.
Rössler, Dieter, et al.. (1993). Cloning, expression and characterization of human kininogen domain 3. FEBS Letters. 321(1). 93–97. 17 indexed citations
15.
Auerswald, Ennes A., et al.. (1992). Recombinant chicken egg white cystatin variants of the QLVSG region. European Journal of Biochemistry. 209(3). 837–845. 55 indexed citations
16.
Assfalg‐Machleidt, Irmgard, G. Rothe, Richard B. Banati, et al.. (1992). Membrane Permeable Fluorogenic Rhodamine Substrates for Selective Determination of Cathepsin L. Biological Chemistry Hoppe-Seyler. 373(2). 433–440. 36 indexed citations
17.
Assfalg‐Machleidt, Irmgard, A. Billing, Dieter Fröhlich, et al.. (1992). The Role of the Kininogens as Cysteine Proteinase Inhibitors in Local and Systemic Inflammation. Birkhäuser Basel eBooks. 38 ( Pt 1). 312–321. 13 indexed citations
18.
Mentele, Reinhardt, et al.. (1991). Recombinant Q53E- and Q53N--chicken egg white cystatin variants inhibit papain, actinidin and cathepsin B.. PubMed. 50(4-6). 621–5. 5 indexed citations
19.
Auerswald, Ennes A., et al.. (1991). Purification and characterization of a chicken egg white cystatin variant expressed in an Escherichia coli pIN‐III‐ompA system. European Journal of Biochemistry. 200(1). 131–138. 29 indexed citations
20.
Assfalg‐Machleidt, Irmgard, et al.. (1988). Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors.. PubMed. 369 Suppl. 263–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas A. Weidner Breakdown of academic impact, for papers by Horst Ahorn Breakdown of academic impact, for papers by Stefan Müller Breakdown of academic impact, for papers by Mikhail A. Nikiforov Breakdown of academic impact, for papers by Robert Schimke Breakdown of academic impact, for papers by M.D. Zimmerman Breakdown of academic impact, for papers by Chunqing Guo Breakdown of academic impact, for papers by Howard O. Fearnhead Breakdown of academic impact, for papers by Ing Swie Goping Breakdown of academic impact, for papers by Giorgio Fassina
Rankless by CCL
2026